Autochthonous tick-borne lymphadenopathy (TIBOLA) in a 3-year-old child caused by Rickettsia slovaca in southwestern Germany [0.03%]
德国西南部一例由R.slovaca引起的3岁儿童土源性蜱传淋巴结病(TIBOLA)
Anne Isaak,Dennis Tappe,Alexandra Veit et al.
Anne Isaak et al.
Ultrasensitive urine LAM testing in HIV-negative tuberculosis: promising progress, but not yet a standalone diagnostic [0.03%]
HIV阴性结核病患者尿液LAM检测呈阳性：前景喜人，但尚不能单独用作诊断方法
Abdul Basit Munir,Haider Imran,Nashmia Faraz
Abdul Basit Munir
Regimen simplification in MDR/RR-TB following the PROSPECT trial [0.03%]
PROSPECT试验后MDR/RR-TB的简化治疗方案
Roberta Maria Antonello,Niccolò Riccardi
Roberta Maria Antonello
Limited, outbreak-biased and unevenly reported: genomic insights into vancomycin-resistant Enterococcus faecium in Germany as reported between 2015 and 2025 [0.03%]
有限的、偏向暴发的和报道不均的：2015至2025年德国报告的耐万古霉素肠球菌属粪肠球菌株的基因组学见解
Anca Rath,Wulf Schneider-Brachert
Anca Rath
Objective: Whole-genome sequencing (WGS) has improved our understanding on epidemiology and transmission of vancomycin-resistant Enterococcus faecium (VRE). However, regional differences in strain distribution patterns re...
Impact of SGLT2 inhibitors on asymptomatic bacteriuria in T2DM: prevalence, pathogens and risk factors [0.03%]
SGLT2抑制剂对T2DM患者无症状菌尿的影响：流行病学、致病菌及危险因素分析
Rahul Hussain,Mohd Aslam,Hamid Ashraf et al.
Rahul Hussain et al.
Introduction: SGLT2 inhibitors (SGLT2i) are extensively used in India for glycemic control, weight management and cardiorenal protection in individuals with type 2 diabetes (T2DM). SGLT2i promotes glucosuria, which may pr...
Correction: Long-term health sequelae and quality of life at least 6 months after infection with SARS-CoV-2: design and rationale of the COVIDOM-study as part of the NAPKON population-based cohort platform (POP) [0.03%]
对SARS-CoV-2感染至少6个月后的长期健康后遗症和生活质量的修正：作为基于人口的队列平台（POP）的一部分，COVIDOM研究的设计与理论依据(NAPKON研究)
A Schäfer,L Krist,W Lieb et al.
A Schäfer et al.
Published Erratum
Infection. 2026 Jul 27. DOI:10.1007/s15010-026-02880-1 2026
Correction: Persistent symptoms and risk factors predicting prolonged time to symptom-free after SARS-CoV-2 infection: an analysis of the baseline examination of the German COVIDOM/NAPKON-POP cohort [0.03%]
纠正：预测SARS-CoV-2感染后持续时间的持久症状和风险因素：德国COVIDOM / NAPKON-POP队列基线检查的分析
Yanyan Shi,Ralf Strobl,Christian Apfelbacher et al.
Yanyan Shi et al.
Published Erratum
Infection. 2026 Jul 27. DOI:10.1007/s15010-026-02881-0 2026
Integrating urban environments into one health approaches to chikungunya [0.03%]
城市环境在登革热“同一健康”方法中的应用集成
Giancarlo Ceccarelli,Francesco Branda,Cecilia Ceccarelli et al.
Giancarlo Ceccarelli et al.
Fosfomycin as an adjunctive agent against carbapenem-resistant Acinetobacter baumannii: an updated narrative review [0.03%]
磷霉素作为防治碳青霉烯耐药鲍曼不动杆菌的辅助用药：综述更新
Luca Pipitò,Eleonora Bono,Chiara Vincenza Mazzola et al.
Luca Pipitò et al.
Carbapenem-resistant Acinetobacter baumannii (CRAB) represents a critical therapeutic challenge due to limited effective treatment options and high associated mortality. Fosfomycin has been increasingly investigated as an adjunctive agent i...
Real-world effectiveness of maternal genetically inactivated acellular pertussis vaccination in protecting infants under three months of age: a case-control study using concurrent community-based and test-negative controls [0.03%]
三月龄以内婴儿百日咳疫苗的母体保护效果：基于社区和检测阴性对照的病例对照研究
Farooq Phiriyasart,Virasakdi Chongsuvivatwong,Ponlagrit Kumwichar
Farooq Phiriyasart
Purpose: Infants too young for primary vaccination face the highest risk of severe pertussis and death. While maternal vaccination is the primary protective strategy, the real-world vaccine effectiveness (VE) of acellular...